Cabergoline Marketed As Dostinex and Cabaser May Be A Treatment Option For Alcoholism
The investigators on this particular study were testing the drug Cabergoline on mice who had been addicted to alcohol and noticed that the cabergoline intake decreased their alcohol intake and reduced their addictive behavior. The Cabergoline injected mice also displayed behavior that they were less likely to experience a relapse. This is potentially a large discovery in the addiction behavior field.
The Biological Psychology Journal stated that Principal Investigator Dorit Ron, PhD, at the Gallo Center and associate professor of neurology at University of California San Francisco, who also led the study, said, "This is encouraging, because it demonstrates that cabergoline is specific for alcohol, but does not affect general reward or pleasure. One of the problems with some existing drugs to treat alcoholism is a side effect that decreases pleasure, making compliance an obstacle to sobriety." Cabergoline looks like it could be a real option to treat alcoholics. Will this get into human testing?
No comments:
Post a Comment